Concepedia

Naritaka Tanaka

NT

Statistics

Publications

31

Citations

1.3K

H-Index

23

Active since

2007

Affiliations

Gunma University(Current)

Dokkyo Medical University

Naritaka Tanaka is an author at Gunma University specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2007–2019

31

Publications

31

<i>MiR‐150</i> is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the <scp>EMT</scp> inducer <i><scp>ZEB</scp>1</i>

Takehiko Yokobori, Shigemasa Suzuki, Naritaka Tanaka et al. · Cancer Science · 2012 · 127 citations · Full text

, , +19

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

Shigemasa Suzuki, Takehiko Yokobori, Naritaka Tanaka et al. · Oncology Reports · 2012 · 95 citations · Full text

, , +16

CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma

Akihiko Sano, Hiroyuki Kato, Shinji Sakurai et al. · Annals of Surgical Oncology · 2008 · 83 citations

, , +8

The clinical application of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

Hiroyuki Kato, Masanobu Nakajima, Makoto Sohda et al. · Cancer · 2009 · 82 citations · Full text

Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.

Makoto Sakai, Makoto Sohda, Tatsuya Miyazaki et al. · PubMed · 2010 · 75 citations

, , +16

1–5 of 31